Compound Evidence File
#EC-2026-0022
CJC-1295
Filed under Peptides. The bureau holds 330 laboratory returns for this compound from 73 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
73 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Apr 2026 | 23 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 10.0 | 10.0 | 1 May 2026 | 15 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 10.0 | 10.0 | 15 Jan 2026 | 18 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Feb 2026 | 5 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 5 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Feb 2026 | 16 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 3 May 2026 | 11 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Feb 2026 | 6 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Apr 2026 | 27 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Apr 2026 | 13 Jul 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | A | 2 | 10.0 | 10.0 | 10.0 | 17 May 2026 | 17 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Mar 2026 | 15 Mar 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Apr 2026 | 27 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Feb 2026 | 6 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Jan 2026 | 5 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Jan 2026 | 9 Apr 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 9 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Jun 2026 | 9 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Nov 2025 | 26 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 20 Apr 2026 | 4 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Dec 2025 | 2 Apr 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Feb 2026 | 10 Jul 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 9.1 | 7.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| NuLife PeptidesCASE #VI-2026-0980 | A | 2 | 9.1 | 8.9 | 9.3 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.9 | 8.5 | 9.2 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.8 | 7.6 | 10.0 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.7 | 7.9 | 9.8 | 25 May 2026 | 25 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.5 | 7.6 | 10.0 | 21 May 2026 | 21 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | A | 5 | 8.3 | 7.2 | 9.5 | 5 May 2025 | 25 Sep 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 7.5 | 7.0 | 8.0 | 19 May 2026 | 19 May 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | B | 14 | 7.3 | 5.3 | 10.0 | 10 Jun 2025 | 25 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | B | 5 | 7.0 | 5.3 | 7.9 | 10 Jun 2025 | 4 Aug 2025 |
| Skye PeptidesCASE #VI-2026-0451 | C | 7 | 6.9 | 4.3 | 8.2 | 17 Dec 2024 | 20 May 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | C | 5 | 6.9 | 5.0 | 8.9 | 17 Dec 2024 | 21 Feb 2025 |
| Verified PeptidesCASE #VI-2026-0407 | C | 5 | 6.8 | 4.1 | 8.4 | 14 Jan 2025 | 21 Feb 2025 |
| Accelerate LabsCASE #VI-2026-0686 | D | 4 | 6.8 | 3.6 | 10.0 | 16 May 2025 | 16 May 2025 |
| Peptide PartnersCASE #VI-2026-0295 | C | 9 | 6.7 | 4.3 | 9.4 | 4 Nov 2025 | 20 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | C | 4 | 6.5 | 4.1 | 7.4 | 13 Feb 2025 | 21 Feb 2025 |
| InjectifyCASE #VI-2026-0387 | C | 7 | 6.4 | 4.7 | 7.0 | 22 Apr 2025 | 16 Jun 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | C | 5 | 6.2 | 5.0 | 8.0 | 28 Feb 2025 | 20 Mar 2025 |
| NextechLabsCASE #VI-2026-0285 | C | 4 | 5.9 | 4.4 | 7.6 | 28 Feb 2025 | 20 Mar 2025 |
| UtherCASE #VI-2026-0902 | E | 5 | 5.8 | 0.0 | 10.0 | 9 Oct 2025 | 25 May 2026 |
| Amino AsylumCASE #VI-2026-0828 | C | 2 | 5.6 | 4.7 | 6.6 | 19 Feb 2025 | 21 Feb 2025 |
| Simple PeptideCASE #VI-2026-0782 | C | 3 | 5.4 | 4.2 | 7.9 | 25 Apr 2025 | 30 Apr 2025 |
| HK PeptidesCASE #VI-2026-0140 | E | 8 | 5.4 | 0.0 | 7.9 | 18 Jul 2025 | 21 May 2026 |
| NexaphCASE #VI-2026-0944 | C | 6 | 5.3 | 4.7 | 6.8 | 10 Jun 2025 | 6 Nov 2025 |
| Reta-PeptideCASE #VI-2026-0756 | E | 6 | 5.2 | 0.0 | 9.9 | 24 Jul 2025 | 26 Jan 2026 |
| Peptide CraftersCASE #VI-2026-0994 | D | 4 | 5.0 | 4.3 | 5.9 | 28 Feb 2025 | 20 Mar 2025 |
| Alpha-GenCASE #VI-2026-0905 | D | 5 | 4.9 | 3.6 | 6.6 | 24 Apr 2025 | 20 May 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | E | 9 | 4.9 | 2.2 | 6.8 | 14 Jan 2025 | 20 May 2025 |
| Peptide GurusCASE #VI-2026-0854 | E | 6 | 4.9 | 2.8 | 7.3 | 16 Mar 2025 | 21 Mar 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | D | 8 | 4.6 | 3.8 | 6.7 | 13 Feb 2025 | 21 Feb 2025 |
| Pure RawzCASE #VI-2026-0767 | D | 4 | 4.6 | 4.0 | 5.5 | 7 May 2025 | 20 May 2025 |
| Elite Research USACASE #VI-2026-0267 | E | 10 | 4.6 | 1.4 | 8.0 | 25 Apr 2025 | 4 Aug 2025 |
| Planet PeptideCASE #VI-2026-0092 | D | 4 | 4.4 | 3.6 | 6.5 | 19 Feb 2025 | 21 Feb 2025 |
| Peptide SciencesCASE #VI-2026-0867 | E | 10 | 4.3 | 2.0 | 7.1 | 19 Feb 2025 | 20 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | D | 3 | 4.1 | 3.8 | 4.4 | 22 Apr 2025 | 5 May 2025 |
| Prime PeptidesCASE #VI-2026-0696 | E | 3 | 4.0 | 1.0 | 10.0 | 20 May 2025 | 3 Jul 2025 |
| SRY LabsCASE #VI-2026-0657 | E | 4 | 3.9 | 0.4 | 5.3 | 10 Jun 2025 | 21 Aug 2025 |
| Astro PeptidesCASE #VI-2026-0424 | E | 8 | 3.8 | 1.8 | 5.7 | 22 Apr 2025 | 5 May 2025 |
| Amino AmigosCASE #VI-2026-0061 | E | 7 | 3.8 | 2.7 | 5.7 | 14 Jan 2025 | 20 Mar 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | E | 4 | 3.7 | 3.1 | 4.2 | 7 May 2025 | 20 May 2025 |
| DeuschemCASE #VI-2026-0004 | E | 4 | 3.7 | 2.1 | 4.7 | 16 Jun 2025 | 4 Aug 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | E | 2 | 3.6 | 2.3 | 4.9 | 14 Jan 2025 | 23 Jan 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | E | 2 | 2.9 | 2.9 | 2.9 | 7 May 2025 | 7 May 2025 |
| Peptides For SaleCASE #VI-2026-0614 | E | 4 | 2.0 | 2.0 | 2.0 | 28 Feb 2025 | 20 Mar 2025 |
| Loti LabsCASE #VI-2026-0171 | E | 5 | 1.5 | 1.1 | 2.0 | 16 Mar 2025 | 5 May 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | E | 2 | 1.1 | 1.1 | 1.2 | 5 May 2025 | 5 May 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | E | 5 | 0.9 | 0.0 | 1.8 | 1 Apr 2025 | 20 May 2025 |
| Swiss ChemsCASE #VI-2026-0030 | E | 3 | 0.9 | 0.8 | 1.0 | 1 Apr 2025 | 5 May 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | E | 3 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 20 May 2025 |
Open any subject to view the batch-level evidence for CJC-1295 alone.